Freddie MAC V/R PFD (FMCCI) Financials
Newest figures come from the 10-Q for Q3 FY2026, filed Oct 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FMCCI SEC filings page.
Freddie MAC V/R PFD (FMCCI) reported $23.3B in revenue for fiscal year 2025, down 2.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
This is a balance-sheet-heavy financial business: liabilities absorb 98.0% of assets, while cash generation swings independently of earnings.
Net income rose13.0% while operating cash flow fell36.1% in the next reported year, showing accounting profit and cash conversion moving apart. The same mismatch continued in the following year: net income rose12.5% as operating cash flow fell13.0% , making earnings quality less stable than the profit line alone suggests.
In FY2025, liabilities were
Long-term debt fell
Financial Health Signals
We do not publish a peer-relative financial health score for Freddie MAC V/R PFD, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Freddie MAC V/R PFD generated $6.8B in revenue in Q3 2026. This represents an increase of 18.7% from the same quarter a year earlier. Against the prior quarter it is up 13.7%.
Freddie MAC V/R PFD reported $3.2B in net income in Q3 2026. This represents an increase of 16.7% from the same quarter a year earlier. Against the prior quarter it is down 15.7%.
Freddie MAC V/R PFD earned $0.01 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Cash & Balance Sheet
Freddie MAC V/R PFD held $4.6B in cash against $157.0B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Freddie MAC V/R PFD's net profit margin was 47.5% in Q3 2026, showing the share of revenue converted to profit. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.6 percentage points.
Freddie MAC V/R PFD's quarterly ROE was 4.0% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
None of these metrics is reported for Q3 2026.
FMCCI Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8B+18.7% | $6.0B+1.3% | N/A | $5.7B-1.7% | $5.9B-1.2% | N/A | $6.3B+17.8% | $5.8B+2.6% |
| SG&A Expenses | $686.0M-4.2% | $676.0M-9.6% | N/A | $716.0M+0.4% | $748.0M+8.6% | N/A | $749.0M | $713.0M |
| Interest Expense | $29.2B+6.1% | $28.3B+5.7% | N/A | $27.5B+10.9% | $26.7B+10.8% | N/A | $25.6B+10.9% | $24.8B+12.5% |
| Income Tax | $781.0M+15.7% | $936.0M+59.2% | N/A | $675.0M-8.9% | $588.0M-15.4% | N/A | $796.0M+8.2% | $741.0M+7.1% |
| Net Income | $3.2B+16.7% | $3.8B+60.8% | N/A | $2.8B-10.7% | $2.4B-13.7% | N/A | $3.2B+10.6% | $3.1B+15.6% |
| EPS (Basic) | $0.01n/m | $0.00n/m | $0.00-100.0% | $0.00n/m | -$0.01n/m | N/A | $0.01n/m | -$0.02n/m |
| EPS (Diluted) | $0.01n/m | $0.00n/m | $0.00-100.0% | $0.00n/m | -$0.01n/m | N/A | $0.01n/m | -$0.02n/m |
| Diluted Shares (Avg) | 3.23B0.0% | 3.23B0.0% | N/A | 3.23B0.0% | 3.23B0.0% | N/A | N/A | 3.23B0.0% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.
FMCCI Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.5T+1.8% | $3.5T+2.4% | $3.5T+3.3% | $3.5T+3.8% | $3.4T+3.9% | $3.4T+3.7% | $3.4T+3.2% | $3.3T+2.2% |
| Cash & Equivalents | $4.6B-1.4% | $4.3B+1.3% | $5.3B-3.7% | $4.6B-4.8% | $4.3B-22.9% | N/A | $5.5B-8.1% | $4.9B-9.3% |
| Total Liabilities | $3.5T+1.5% | $3.4T+2.0% | $3.4T+3.0% | $3.4T+3.5% | $3.4T+3.6% | $3.3T+3.4% | $3.3T+2.9% | $3.3T+1.8% |
| Long-Term Debt | $157.0B | $163.7B | $169.3B+1.2% | N/A | N/A | N/A | $167.3B-94.8% | $3.3T+1.7% |
| Total Equity | $81.0B+19.8% | $77.8B+20.0% | $70.4B+18.1% | $67.6B+19.9% | $64.8B+21.8% | $62.4B+23.7% | $59.6B+24.8% | $56.4B+26.3% |
| Retained Earnings | -$1.9Bn/m | -$5.1Bn/m | -$12.5Bn/m | -$15.3Bn/m | -$18.1Bn/m | -$20.5Bn/m | -$23.3Bn/m | -$26.5Bn/m |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
FMCCI Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.2B-16.9% | N/A | $2.6Bn/m | $5.1B+37.1% | N/A | N/A | -$900.0M-147.8% | $3.7B+410.5% |
| Investing Cash Flow | $17.0Bn/m | N/A | $4.7Bn/m | -$881.0M-200.7% | N/A | N/A | -$13.6B-181.8% | $875.0M-96.1% |
| Financing Cash Flow | -$21.0Bn/m | N/A | -$6.6B-143.5% | -$3.8Bn/m | N/A | N/A | $15.2Bn/m | -$5.3Bn/m |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
FMCCI Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 47.5%-0.8pp | 64.1%+23.7pp | N/A | 48.3%-4.9pp | 40.4%-5.8pp | N/A | 50.9%-3.3pp | 53.2%+6.0pp |
| Return on Equity | 4.0%-0.1pp | 4.9%+1.3pp | N/A | 4.1%-1.4pp | 3.7%-1.5pp | N/A | 5.4%-0.7pp | 5.5%-0.5pp |
| Return on Assets | 0.1%0.0pp | 0.1%0.0pp | N/A | 0.1%0.0pp | 0.1%0.0pp | N/A | 0.1%0.0pp | 0.1%0.0pp |
| Debt-to-Equity | 1.94 | 2.11 | 2.41-0.4x | N/A | N/A | N/A | 2.81-64.3x | 57.66-13.9x |
| Liabilities-to-Equity | 42.62-7.7x | 44.24-7.8x | 48.69-7.2x | 50.30-8.0x | 52.02-9.1x | 53.63-10.5x | 55.85-11.9x | 58.28-14.0x |
| Asset Turnover | 0.000.0x | 0.000.0x | N/A | 0.000.0x | 0.000.0x | N/A | 0.000.0x | 0.000.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Freddie MAC V/R PFD FMCCI | FY2025 | $23.3B | N/A | N/A | N/A | — |
| Fannie MAE FNMA | FY2025 | $29.2B | $14.4B | 49.3% | $5.1B | — |
Where Freddie MAC V/R PFD Ranks
Frequently Asked Questions
Freddie MAC V/R PFD (FMCCI) reported $23.3B in total revenue for fiscal year 2025. This represents a -2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Freddie MAC V/R PFD (FMCCI) revenue declined by 2.7% year-over-year, from $23.9B to $23.3B in fiscal year 2025.
As of fiscal year 2025, Freddie MAC V/R PFD (FMCCI) had $5.3B in cash and equivalents against $169.3B in long-term debt.
Freddie MAC V/R PFD (FMCCI) generated $19.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Freddie MAC V/R PFD (FMCCI) had $3.5T in total assets as of fiscal year 2025, including both current and long-term assets.
Freddie MAC V/R PFD (FMCCI) had a debt-to-equity ratio of 2.41 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Freddie MAC V/R PFD (FMCCI) had a liabilities-to-equity ratio of 48.69 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.